Medication-Assisted Treatment (MAT) is a clinically proven approach for treating opioid use disorder. At Advene Health, we provide structured, compassionate MAT services designed to reduce cravings, manage withdrawal symptoms, and support long-term recovery.
Our integrated model combines medication management with behavioral health services, ensuring every patient receives coordinated medical and therapeutic support in one professional setting.
If you are struggling with opioid dependence, fentanyl addiction, or prescription pain medication misuse, MAT may provide the stability needed to begin rebuilding your life.
MAT works by:
Reducing opioid cravings
Minimizing withdrawal symptoms
Lowering relapse risk
Supporting brain stabilization
Allowing full participation in therapy and recovery planning
Medication-Assisted Treatment (MAT)
Suboxone is a commonly prescribed medication that combines buprenorphine and naloxone to help reduce cravings and withdrawal symptoms while lowering the risk of misuse. It is widely used as part of Medication-Assisted Treatment (MAT) for opioid use disorder.
At Advene Health, Suboxone treatment includes medical evaluation, individualized dosing, and ongoing monitoring, combined with integrated behavioral health support to promote safe and sustainable recovery outcomes.
Sublocade is a long-acting injectable form of buprenorphine administered monthly. It provides consistent medication levels and may improve adherence for individuals seeking a structured option.
Sublocade may be appropriate for patients who have stabilized on oral buprenorphine and prefer a monthly injection.
Brixadi is an extended-release buprenorphine injection available in weekly or monthly dosing options. It offers flexible long-acting treatment for opioid use disorder.
For eligible patients, Brixadi may be covered under Medicaid and other insurance plans.
